BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24219035)

  • 1. Mechanisms of action of methotrexate.
    Chan ES; Cronstein BN
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S5-8. PubMed ID: 24219035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases.
    Furst DE
    Br J Rheumatol; 1997 Nov; 36(11):1196-204. PubMed ID: 9402864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reducing toxicity of methotrexate with folic acid].
    Harten P
    Z Rheumatol; 2005 Jun; 64(5):353-8. PubMed ID: 15965822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How to effectively use methotrexate in rheumatoid arthritis?].
    Hernandez-Baldizon S
    Reumatol Clin; 2012; 8(1):42-5. PubMed ID: 22089073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate--the anchor drug--an introduction.
    Pincus T; Cronstein B; Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S1-2. PubMed ID: 21044424
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.
    Stamp LK; Roberts RL
    Pharmacogenomics; 2011 Oct; 12(10):1449-63. PubMed ID: 22008049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of methotrexate in childhood rheumatic diseases.
    Wallace CA
    Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose and high-dose methotrexate are two different drugs in practical terms.
    Malaviya AN; Sharma A; Agarwal D; Kapoor S; Garg S; Sawhney S
    Int J Rheum Dis; 2010 Oct; 13(4):288-93. PubMed ID: 21199463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha inhibitors and methotrexate: implications for deployed personnel.
    Martin JJ
    Aviat Space Environ Med; 2005 Dec; 76(12):1162-6. PubMed ID: 16370267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
    Castrejón I; Gibson KA; Pincus T
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of MTX in the elderly and in patients with compromised renal function.
    Morgacheva O; Furst DE
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S85-94. PubMed ID: 21044439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].
    Briem S; Lorenz HM
    Z Rheumatol; 2011 Feb; 70(2):123-8. PubMed ID: 21267732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events in methotrexate-treated rheumatoid arthritis patients.
    Sandoval DM; Alarcón GS; Morgan SL
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():49-56. PubMed ID: 8535650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
    Weber-Schoendorfer C; Chambers C; Wacker E; Beghin D; Bernard N; ; Shechtman S; Johnson D; Cuppers-Maarschalkerweerd B; Pistelli A; Clementi M; Winterfeld U; Eleftheriou G; Pupco A; Kao K; Malm H; Elefant E; Koren G; Vial T; Ornoy A; Meister R; Schaefer C
    Arthritis Rheumatol; 2014 May; 66(5):1101-10. PubMed ID: 24470106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α.
    Benedek TG
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S3-8. PubMed ID: 21044425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of adolescents with rheumatic disease.
    Hollister JR
    Adolesc Med; 1998 Feb; 9(1):163-70, vii. PubMed ID: 10961259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate induced lymphoma?
    Bleyer WA
    J Rheumatol; 1998 Mar; 25(3):404-7. PubMed ID: 9517755
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chinese expert-based consensus for methotrexate in rheumatic diseases].
    Chinese Association of Rheumatology and Immunology Physicians
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.